|
Status |
Public on Apr 01, 2018 |
Title |
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Expression profiling by array Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
29973406 |
|
Submission date |
Aug 03, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Ashish Lal |
E-mail(s) |
ashish.lal@nih.gov
|
Phone |
2407607396
|
Organization name |
NCI, NIH
|
Department |
Genetics Branch
|
Lab |
Javed Khan
|
Street address |
37 Convent Dr.
|
City |
Bethesda |
State/province |
MD |
ZIP/Postal code |
20892 |
Country |
USA |
|
|
Platforms (3) |
GPL1261 |
[Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (60)
|
GSM2259121 |
NRAS_Q61K |
GSM2259122 |
CTR DNase DMSO 48h rep 1 |
GSM2259123 |
CTR DNase DMSO 48h rep 2 |
GSM2259124 |
CTR DNase DMSO 48h rep 3 |
GSM2259125 |
CTR DNase Tram 48h rep 1 |
GSM2259126 |
CTR DNase Tram 48h rep 2 |
GSM2259127 |
CTR DNase Tram 48h rep 3 |
GSM2259128 |
CTR DNase 48h rep 1 |
GSM2259129 |
CTR DNase 48h rep 2 |
GSM2259130 |
CTR DNase 48h rep 3 |
GSM2259131 |
CTR D48 ERK |
GSM2259132 |
CTR T48 ERK |
GSM2259133 |
CTR D48 EZH2 |
GSM2259134 |
CTR T48 EZH2 |
GSM2259135 |
CTR D48 H3K27ac |
GSM2259136 |
CTR T48 H3K27ac rep 1 |
GSM2259137 |
CTR T48 H3K27ac rep 2 |
GSM2259138 |
CTR D48 H3K27me3 rep 1 |
GSM2259139 |
CTR T48 H3K27me3 rep 1 |
GSM2259140 |
CTR D48 H3K27me3 rep 2 |
GSM2259141 |
CTR T48 H3K27me3 rep 2 |
GSM2259142 |
CTR D48 H3K36me3 |
GSM2259143 |
CTR D48 H3K4me1 |
GSM2259144 |
CTR D48 H3K4me2 |
GSM2259145 |
CTR D48 H3K4me3 |
GSM2259146 |
CTR T48 input |
GSM2259147 |
CTR D48 input rep 1 |
GSM2259148 |
CTR D48 input rep 2 |
GSM2259152 |
CTR T48 MYOD1 |
GSM2259153 |
CTR D48 MYOD1 rep 1 |
GSM2259154 |
CTR D48 MYOD1 rep 2 |
GSM2259155 |
CTR D48 MYOG |
GSM2259156 |
CTR T48 MYOG |
GSM2259157 |
CTR D48 PolII |
GSM2259158 |
CTR T48 PolII |
GSM2259159 |
CTR untreated |
GSM2259160 |
CTR DMSO |
GSM2259161 |
CTR 10 nM Tram, 6 hrs |
GSM2259162 |
CTR 10 nM Tram, 24 hrs |
GSM2259163 |
CTR 10 nM Tram, 48 hrs |
GSM2259164 |
CTR 100 nM Tram, 6 hrs |
GSM2259165 |
CTR 100 nM Tram, 24 hrs |
GSM2259166 |
CTR 100 nM Tram, 48 hrs |
GSM2259167 |
RD si control |
GSM2259168 |
RD si MEK1 |
GSM2259169 |
RD untreated |
GSM2259170 |
RD DMSO |
GSM2259171 |
RD 10 nM Tram, 6 hrs |
GSM2259172 |
RD 10 nM Tram, 24 hrs |
GSM2259173 |
RD 10 nM Tram, 48 hrs |
GSM2259174 |
RD 100 nM Tram, 6 hrs |
GSM2259175 |
RD 100 nM Tram, 24 hrs |
GSM2259176 |
RD 100 nM Tram, 48 hrs |
GSM3103104 |
CTR D48 MYCy69 |
GSM3103105 |
CTR T48 MYCy69 |
GSM3103106 |
CTR D48 Pol2S2pAMR |
GSM3103107 |
CTR T48 Pol2S2pAMR |
|
This SuperSeries is composed of the following SubSeries: |
GSE85168 |
Oncogenic RAS blocks myogenic differentiation |
GSE85169 |
MEK inhibition profoundly reprograms myogenic super enhancers in mutant-RAS driven Rhabdomyosarcoma |
GSE85170 |
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block |
|
Relations |
BioProject |
PRJNA336377 |